Infectious Diseases News and Research

RSS

Independent examines diseases that jump from animals to humans

The Independent examines the expansion of human diseases that originated in animals. "At least 45 diseases that have passed from animals to humans have been reported to U.N. agencies in the last two decades, with the number expected to escalate in the coming years," the Independent writes.

5 Jan 2010

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

The presence of the Streptococcus pneumoniae in samples that can be easily obtained in clinics and emergency rooms may predict risk of severe disease in H1N1 pandemic influenza.

31 Dec 2009

Oxford Outcomes becomes a member of SAFE-BioPharma Association

Oxford Outcomes, an international health outcomes consultancy, has become a member of SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

24 Dec 2009

Cardiac marker POC test: A successful concept of point-of-care diagnostics

Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.

24 Dec 2009

Motility mechanism of malaria pathogens explained

How do one-celled parasites move from the salivary gland of a mosquito through a person's skin into red blood cells? What molecular mechanisms form the basis for this very important movement of the protozoa?

23 Dec 2009

GlobalPost examines antibiotic resistance in China

GlobalPost examines antibiotic resistance and overprescribing in China. The country "has high rates of antibiotic resistance and a health care system that provides strong financial incentives for over-prescribing antibiotics.

23 Dec 2009

Autism study and gene therapy in vision are top scientific achievements in 2009

A landmark autism study and a dramatic success for gene therapy in reversing inherited blindness, both at The Children's Hospital of Philadelphia, were recognized among the top scientific achievements in 2009, according to three national publications: Time magazine, Discover magazine and the journal Science.

23 Dec 2009

Microbial Pathogenomics: A collection of reviews and future trends in bacterial pathogenomics

'Microbial Pathogenomics' contains a unique collection of reviews demonstrating how genomics has revolutionized our understanding of virulence, host-adaptation strategies and the evolution of bacterial pathogens. Current technologies - computational tools and functional approaches to genome analysis - are carefully documented and clearly illustrated.

23 Dec 2009

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

A McMaster University researcher has found the first evidence that prolonged exposure to higher levels of the pollutants found in car exhaust fumes and industrial air pollution can lead to hospitalization for pneumonia in adults aged 65 and older.

23 Dec 2009

New community-associated strain of MRSA more apt to cause serious problems

The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.

23 Dec 2009

Guardian Technologies International meets and presents SM TBDx to Indian healthcare officials

Tuberculosis (TB) continues to be a serious global pandemic health threat with more than 9 million new cases diagnosed annually. TB is a leading cause of mortality in India, killing nearly 1,000 people each day.

23 Dec 2009

Former CDC head to lead Merck's vaccine division

The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.

22 Dec 2009

Cell Medica receives second grant for development of adenovirus infection therapy

Cell Medica, a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer, has announced that is has appointed four key staff to drive forwards the Company’s activities in the commercialisation of cell therapy treatments.

22 Dec 2009

UV Flu Technologies introduces the UV 400 VIRAGUARD air purification product

UV Flu Technologies, Inc. wishes to advise it has recently acquired the assets of AmAirpure, Inc. in order to implement management's plans to move forward as an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality("IAQ") industry sector.

22 Dec 2009

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

An experiemental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria. The researchers from Japan report their findings in the December 2009 issue of the journal Infection and Immunity.

19 Dec 2009

Second wave of H1N1 virus infection in the U.S. comes to an end

Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the "second wave" of virus infection that sickened tens of millions of Americans since it began four months ago may be coming to an end, according to a new report by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services.

19 Dec 2009

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Despite a 100-fold increase in H1N1 influenza cases in the Seattle area during spring 2009, an aggressive infection control program to protect immunocompromised cancer patients and thorough screening measures resulted in no corresponding increase in H1N1 cases among the total patient population at the Seattle Cancer Care Alliance, according to a new study by researchers and physicians at Fred Hutchinson Cancer Research Center and the SCCA.

19 Dec 2009

Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been.

19 Dec 2009

New ways of treating infections identified by researchers at Binghamton University

Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.

19 Dec 2009

Orphanage care in developing countries is a 'viable option,' study finds

A study, published on Thursday in PLoS One, finds that the "care at orphanages [in developing countries] is often at least as good as that given by families who take in orphaned or abandoned children," challenging "the widespread belief that orphans in poor countries fare best in family-style homes in the community and should be put into orphanages only as a last resort," the New York Times reports (Grady, 12/17).

18 Dec 2009

Infectious Diseases News and Research

Independent examines diseases that jump from animals to humans

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

Oxford Outcomes becomes a member of SAFE-BioPharma Association

Cardiac marker POC test: A successful concept of point-of-care diagnostics

Motility mechanism of malaria pathogens explained

GlobalPost examines antibiotic resistance in China

Autism study and gene therapy in vision are top scientific achievements in 2009

Microbial Pathogenomics: A collection of reviews and future trends in bacterial pathogenomics

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

New community-associated strain of MRSA more apt to cause serious problems

Guardian Technologies International meets and presents SM TBDx to Indian healthcare officials

Former CDC head to lead Merck's vaccine division

Cell Medica receives second grant for development of adenovirus infection therapy

UV Flu Technologies introduces the UV 400 VIRAGUARD air purification product

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

Second wave of H1N1 virus infection in the U.S. comes to an end

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

New ways of treating infections identified by researchers at Binghamton University

Orphanage care in developing countries is a 'viable option,' study finds

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News